Norfloxacin does not alter warfarin's disposition or anticoagulant effect

Area of Science:

• Pharmacology
• Drug Metabolism
• Clinical Pharmacy

Background:

• Fluoroquinolone antibiotics can inhibit hepatic drug metabolism, leading to potential drug interactions.
• The interaction between norfloxacin and warfarin, a common anticoagulant, requires investigation.

Purpose of the Study:

• To determine if norfloxacin interacts with warfarin at standard clinical doses.
• To assess the impact of norfloxacin on warfarin's pharmacokinetic and pharmacodynamic profiles.

Main Methods:

• A randomized, crossover study involving 10 healthy males.
• Administration of warfarin alone versus during multiple-dose norfloxacin treatment.
• Measurement of plasma warfarin concentrations and prothrombin times over 6 days.

Main Results:

• Norfloxacin did not significantly alter warfarin's elimination half-life, clearance, volume of distribution, or peak plasma concentration.
• No significant differences were observed in warfarin's anticoagulant effect (prothrombin time) with or without norfloxacin.
• Pharmacokinetic and pharmacodynamic parameters of warfarin remained comparable between treatment groups.

Conclusions:

• Norfloxacin is unlikely to cause clinically significant pharmacokinetic or pharmacodynamic interactions with warfarin.
• Concurrent use of norfloxacin and warfarin in patients may be safe without dose adjustments.
• Further clinical studies may confirm the safety profile in diverse patient populations.